High Pasta vs. Low Pasta Diet in the Treatment of Obesity

Sponsor
University of Parma (Other)
Overall Status
Completed
CT.gov ID
NCT03341650
Collaborator
(none)
44
1
2
25
1.8

Study Details

Study Description

Brief Summary

To the best of our knowledge, the effect of pasta consumption within a hypocaloric Mediterranean diet has only been scarcely explored yet. Therefore, a two-parallel group dietary intervention was carried out to investigate if pasta consumption could affect the BMI change in obese patients. The primary outcome was the loss of at leat 8% of the initial body weight in the first 6 months. Anthropometric and body composition (from bioelectrical impedance analysis - BIA-) measures were collected every month for the first 6 months and after 1 year. In addition, dietary information was collected at baseline and after 3, 6 and 12 months through a 7-day carbohydrate food record and a 24-h food recall. Blood samples were collected at baseline and at 6 and 12 months to assess: glucose, insulin, Homeostatic model assessment for insulin resistant (HOMA-IR) index, total cholesterol, low-density lipoprotein, high-density lipoprotein, and uric acid. Furthermore, the perceived quality of life was investigated through the 36-items short form health survey (SF36) questionnaire.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: High Pasta
  • Behavioral: Low Pasta
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
44 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
The Effect of High Pasta vs. Low Pasta Mediterranean Diet on Weight Loss in the Treatment of Obese Patients
Actual Study Start Date :
Nov 2, 2015
Actual Primary Completion Date :
Dec 1, 2017
Actual Study Completion Date :
Dec 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: High Pasta

Habitual pasta consumption equal or higher than 5 times/week.

Behavioral: High Pasta
Participants received a personalised diet program considering their food preferences and eating behaviour, based on the Italian guidelines for a healthy and Mediterranean diet and were encouraged to maintain their habitual consumption of pasta (at least 5 times/week). To encourage participants to prepare healthy meals by using high-quality ingredients, participants were provided with a recipe book and dietary guidelines and recommendations.

Experimental: Low Pasta

Habitual pasta consumption equal or lower than 3 times/week.

Behavioral: Low Pasta
Participants received a personalised diet program considering their food preferences and eating behaviour, based on the Italian guidelines for a healthy and Mediterranean diet and were encouraged to maintain their habitual consumption of pasta (no more than 3 times/week). To encourage participants to prepare healthy meals by using high-quality ingredients, participants were provided with a recipe book and dietary guidelines and recommendations.

Outcome Measures

Primary Outcome Measures

  1. Change from baseline Body weight at 6 months [baseline, 6 months]

    Measured in kg according to the standard procedure

Secondary Outcome Measures

  1. Change from baseline Body weight at 3 months [baseline, 3 months]

    Measured in kg according to the standard procedure

  2. Change from baseline Body weight at 12 months [baseline, 12 months]

    Measured in kg according to the standard procedure

  3. BMI [baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 12 months]

    Calculated as body weight in kilograms divided by the square of the height in meters

  4. Waist circumference [baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 12 months]

    Measured in cm according to the standard procedure

  5. Free Fat Mass [baseline, 3 months, 6 months, 12 months]

    Estimated by bioelectrical impedance analysis in kg and in %

  6. Fat Mass [baseline, 3 months, 6 months, 12 months]

    Estimated by bioelectrical impedance analysis in kg and in %

  7. Basal Metabolic Rate [baseline, 3 months, 6 months, 12 months]

    Estimated by bioelectrical impedance analysis in kcal/day

  8. Glucose [baseline, 6 months, 12 months]

    mg/dL in fasting condition

  9. Insulin [baseline, 6 months, 12 months]

    microU/mL in fasting condition

  10. HOMA-IR index [baseline, 6 months, 12 months]

    calculated from glucose and insulin in fasting condition

  11. Total cholesterol [baseline, 6 months, 12 months]

    mg/dL in fasting condition

  12. HDL cholesterol [baseline, 6 months, 12 months]

    mg/dL in fasting condition

  13. LDL cholesterol [baseline, 6 months, 12 months]

    mg/dL in fasting condition

  14. Triglycerides [baseline, 6 months, 12 months]

    mg/dL in fasting condition

  15. Uric Acid [baseline, 6 months, 12 months]

    mg/dL in fasting condition

  16. Energy intake [baseline, 3 months, 6 months, 12 months]

    assessed by a 24-h dietary recall as kcal/day

  17. Nutrient intakes [baseline, 3 months, 6 months, 12 months]

    assessed by a 24-h dietary recall as g/day

  18. Carbohydrate-based food intakes [baseline, 3 months, 6 months, 12 months]

    assessed by a 7-day food diary as times/week

  19. Perceived Quality of Life [baseline, 3 months, 6 months, 12 months]

    assessed by the SF36 questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • BMI between 30-45 kg/m2

  • healthy subjects

  • regular meal consumption

  • no celiac disease

  • no menopause woman

Exclusion Criteria:
  • with a BMI <30 or >45 kg/m2

  • having diabetes, hepatic or kidney diseases

  • having an eating disorder

  • having celiac disease

  • menopause woman

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Food and Drug, University of Parma Parma Italy 43125

Sponsors and Collaborators

  • University of Parma

Investigators

  • Study Director: Elisabetta Dall'Aglio, MD, University of Parma

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Francesca Scazzina Ph.D., Assistant Professor, University of Parma
ClinicalTrials.gov Identifier:
NCT03341650
Other Study ID Numbers:
  • SP2
First Posted:
Nov 14, 2017
Last Update Posted:
May 4, 2018
Last Verified:
Nov 1, 2017
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Francesca Scazzina Ph.D., Assistant Professor, University of Parma

Study Results

No Results Posted as of May 4, 2018